Enzyme-linked immunosorbent assay (ELISA) kits validated for canine samples are widely used in veterinary research and clinical diagnostics for the detection and quantification of proteins, cytokines, antibodies, antigens, hormones, and other biomarkers. These assays are designed for use with canine biological matrices, including serum, plasma, urine, and tissue lysates derived from Canis lupus familiaris.

Canine ELISA kits are valued for their high analytical sensitivity, specificity, and reproducibility, enabling reliable measurement of low-abundance analytes. As a result, they play a critical role in studying disease mechanisms, monitoring immune responses, and identifying biomarkers relevant to canine health and disease progression.

Scientific and Clinical Applications of Canine ELISA Kits

Infectious Disease Research and Diagnosis

Canine ELISA kits are routinely employed to detect pathogen-specific antibodies or antigens associated with infectious diseases such as canine parvovirus, canine distemper virus, canine adenovirus, and infectious canine hepatitis. ELISA-based serological assays provide rapid, sensitive, and specific detection, supporting:

• Diagnosis of active or prior infection

• Evaluation of vaccine-induced immune responses

• Longitudinal monitoring of antibody titers

• Epidemiological surveillance within canine populations

Compared with traditional diagnostic methods, ELISA assays offer improved throughput and quantitative output.

Technical Advantages of Canine ELISA Kits

Canine ELISA kits are typically optimized for canine-specific targets and incorporate antibodies validated for reactivity with canine analytes. Key technical advantages include:

• High specificity for canine proteins and antigens

• Small sample volume requirements (often as low as 10 µL)

• Compatibility with standard laboratory equipment

• Suitability for both research and routine diagnostic use

These features contribute to the widespread adoption of ELISA in veterinary laboratories.